Approximately 90 % of individuals affected with OI are heterozygous for a causative variant in one of the two genes, COL1A1 or COL1A2, which encode the pro-1(I) and pro-2(I) chains of type I procollagen, respectively [6]. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.